Peter M. Clarke
Corporate Officer/Principal bei SAVARA INC.
Aktive Positionen von Peter M. Clarke
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SAVARA INC. | Corporate Officer/Principal | 01.09.2021 | - |
Karriereverlauf von Peter M. Clarke
Ehemalige bekannte Positionen von Peter M. Clarke
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| INSMED INCORPORATED | Technik-/Wissenschafts-/F&E-Leiter | 19.03.2014 | - |
| Corporate Officer/Principal | 07.05.2013 | 19.03.2014 | |
| INTROGEN THERPUT | Corporate Officer/Principal | 01.02.2004 | - |
Ausbildung von Peter M. Clarke
| University of London | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| Vereinigtes Königreich | 2 |
Operativ
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| INSMED INCORPORATED | Health Technology |
| SAVARA INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Introgen Therapeutics, Inc.
 Introgen Therapeutics, Inc. Medical SpecialtiesHealth Technology Introgen Therapeutics, Inc. is a biopharmaceutical company focuses on the discovery, development and commercialization of targeted molecular therapies for the treatment of cancer and other diseases. The company develops molecular therapeutics, immunotherapies, vaccines and nano-particle tumor suppressor therapies to treat a wide range of cancers using tumor suppressors, cytokines and genes. The company maintains integrated research, development, manufacturing, clinical and regulatory departments and operates multiple manufacturing facilities including a commercial scale cGMP manufacturing facility. It was founded in June 1993 and is headquartered in Austin, TX. | Health Technology |
- Börse
- Insiders
- Peter M. Clarke
- Erfahrung
